Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries
Identifieur interne : 000490 ( Main/Exploration ); précédent : 000489; suivant : 000491Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries
Auteurs : Catherine E. Vialle-Valentin [États-Unis] ; Brian Serumaga [États-Unis] ; Anita K. Wagner [États-Unis] ; Dennis Ross-Degnan [États-Unis]Source :
- Health Policy and Planning [ 0268-1080 ] ; 2014.
Abstract
The 2011 United Nations (UN) General Assembly Political Declaration on Prevention and Control of Non-Communicable Diseases (NCDs) brought NCDs to the global health agenda. Essential medicines are central to treating chronic diseases such as hypertension and diabetes. Our study aimed to quantify access to essential medicines for people with chronic conditions in five low- and middle-income countries and to evaluate how household socioeconomic status and perceptions about medicines availability and affordability influence access. We analysed data for 1867 individuals with chronic diseases from national surveys (Ghana, Jordan, Kenya, Philippines and Uganda) conducted in 2007–10 using a standard World Health Organization (WHO) methodology to measure medicines access and use. We defined individuals as having access to medicines if they reported regularly taking medicine for a diagnosed chronic disease and data collectors found a medicine indicated for that disease in their homes. We used logistic regression models accounting for the clustered survey design to investigate determinants of keeping medicines at home and predictors of access to medicines for chronic diseases. Less than half of individuals previously diagnosed with a chronic disease had access to medicines for their condition in every country, from 16% in Uganda to 49% in Jordan. Other than reporting a chronic disease, higher household socioeconomic level was the most significant predictor of having any medicines available at home. The likelihood of having access to medicines for chronic diseases was higher for those with medicines insurance coverage [highest adjusted odds ratio (OR) 3.12 (95% confidence intervals (CI): 1.38, 7.07)] and lower for those with past history of borrowing money to pay for medicines [lowest adjusted OR 0.56 (95% CI: 0.34, 0.92)]. Our study documents poor access to essential medicines for chronic conditions in five resource-constrained settings. It highlights the importance of financial risk protection and consumer education about generic medicines in global efforts towards improving treatment of chronic diseases.
Url:
DOI: 10.1093/heapol/czu107
PubMed: 25255920
PubMed Central: 4654757
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000006
- to stream Pmc, to step Curation: 000006
- to stream Pmc, to step Checkpoint: 000251
- to stream Ncbi, to step Merge: 000697
- to stream Ncbi, to step Curation: 000697
- to stream Ncbi, to step Checkpoint: 000697
- to stream Main, to step Merge: 000490
- to stream Main, to step Curation: 000490
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries</title><author><name sortKey="Vialle Valentin, Catherine E" sort="Vialle Valentin, Catherine E" uniqKey="Vialle Valentin C" first="Catherine E" last="Vialle-Valentin">Catherine E. Vialle-Valentin</name><affiliation wicri:level="2"><nlm:aff id="czu107-AFF1">Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Serumaga, Brian" sort="Serumaga, Brian" uniqKey="Serumaga B" first="Brian" last="Serumaga">Brian Serumaga</name><affiliation wicri:level="2"><nlm:aff id="czu107-AFF1">JSI Research and Training Inc., 1616 N Fort Myer Drive, Arlington, VA 22209, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>JSI Research and Training Inc., 1616 N Fort Myer Drive, Arlington, VA 22209</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Wagner, Anita K" sort="Wagner, Anita K" uniqKey="Wagner A" first="Anita K" last="Wagner">Anita K. Wagner</name><affiliation wicri:level="2"><nlm:aff id="czu107-AFF1">Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Ross Degnan, Dennis" sort="Ross Degnan, Dennis" uniqKey="Ross Degnan D" first="Dennis" last="Ross-Degnan">Dennis Ross-Degnan</name><affiliation wicri:level="2"><nlm:aff id="czu107-AFF1">Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">25255920</idno><idno type="pmc">4654757</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654757</idno><idno type="RBID">PMC:4654757</idno><idno type="doi">10.1093/heapol/czu107</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">000006</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000006</idno><idno type="wicri:Area/Pmc/Curation">000006</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000006</idno><idno type="wicri:Area/Pmc/Checkpoint">000251</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000251</idno><idno type="wicri:Area/Ncbi/Merge">000697</idno><idno type="wicri:Area/Ncbi/Curation">000697</idno><idno type="wicri:Area/Ncbi/Checkpoint">000697</idno><idno type="wicri:doubleKey">0268-1080:2014:Vialle Valentin C:evidence:on:access</idno><idno type="wicri:Area/Main/Merge">000490</idno><idno type="wicri:Area/Main/Curation">000490</idno><idno type="wicri:Area/Main/Exploration">000490</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries</title><author><name sortKey="Vialle Valentin, Catherine E" sort="Vialle Valentin, Catherine E" uniqKey="Vialle Valentin C" first="Catherine E" last="Vialle-Valentin">Catherine E. Vialle-Valentin</name><affiliation wicri:level="2"><nlm:aff id="czu107-AFF1">Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Serumaga, Brian" sort="Serumaga, Brian" uniqKey="Serumaga B" first="Brian" last="Serumaga">Brian Serumaga</name><affiliation wicri:level="2"><nlm:aff id="czu107-AFF1">JSI Research and Training Inc., 1616 N Fort Myer Drive, Arlington, VA 22209, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>JSI Research and Training Inc., 1616 N Fort Myer Drive, Arlington, VA 22209</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Wagner, Anita K" sort="Wagner, Anita K" uniqKey="Wagner A" first="Anita K" last="Wagner">Anita K. Wagner</name><affiliation wicri:level="2"><nlm:aff id="czu107-AFF1">Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Ross Degnan, Dennis" sort="Ross Degnan, Dennis" uniqKey="Ross Degnan D" first="Dennis" last="Ross-Degnan">Dennis Ross-Degnan</name><affiliation wicri:level="2"><nlm:aff id="czu107-AFF1">Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></analytic><series><title level="j">Health Policy and Planning</title><idno type="ISSN">0268-1080</idno><idno type="eISSN">1460-2237</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p> The 2011 United Nations (UN) General Assembly Political Declaration on Prevention and Control of Non-Communicable Diseases (NCDs) brought NCDs to the global health agenda. Essential medicines are central to treating chronic diseases such as hypertension and diabetes. Our study aimed to quantify access to essential medicines for people with chronic conditions in five low- and middle-income countries and to evaluate how household socioeconomic status and perceptions about medicines availability and affordability influence access. We analysed data for 1867 individuals with chronic diseases from national surveys (Ghana, Jordan, Kenya, Philippines and Uganda) conducted in 2007–10 using a standard World Health Organization (WHO) methodology to measure medicines access and use. We defined individuals as having access to medicines if they reported regularly taking medicine for a diagnosed chronic disease and data collectors found a medicine indicated for that disease in their homes. We used logistic regression models accounting for the clustered survey design to investigate determinants of keeping medicines at home and predictors of access to medicines for chronic diseases. Less than half of individuals previously diagnosed with a chronic disease had access to medicines for their condition in every country, from 16% in Uganda to 49% in Jordan. Other than reporting a chronic disease, higher household socioeconomic level was the most significant predictor of having any medicines available at home. The likelihood of having access to medicines for chronic diseases was higher for those with medicines insurance coverage [highest adjusted odds ratio (OR) 3.12 (95% confidence intervals (CI): 1.38, 7.07)] and lower for those with past history of borrowing money to pay for medicines [lowest adjusted OR 0.56 (95% CI: 0.34, 0.92)]. Our study documents poor access to essential medicines for chronic conditions in five resource-constrained settings. It highlights the importance of financial risk protection and consumer education about generic medicines in global efforts towards improving treatment of chronic diseases.</p></div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li><li>Virginie</li></region></list><tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Vialle Valentin, Catherine E" sort="Vialle Valentin, Catherine E" uniqKey="Vialle Valentin C" first="Catherine E" last="Vialle-Valentin">Catherine E. Vialle-Valentin</name></region><name sortKey="Ross Degnan, Dennis" sort="Ross Degnan, Dennis" uniqKey="Ross Degnan D" first="Dennis" last="Ross-Degnan">Dennis Ross-Degnan</name><name sortKey="Serumaga, Brian" sort="Serumaga, Brian" uniqKey="Serumaga B" first="Brian" last="Serumaga">Brian Serumaga</name><name sortKey="Wagner, Anita K" sort="Wagner, Anita K" uniqKey="Wagner A" first="Anita K" last="Wagner">Anita K. Wagner</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000490 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000490 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:4654757
|texte= Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25255920" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |